Arcturus Therapeutics Holdings Inc (ARCT)
SG&A Expenses
$44.22M
TTM · Period ending: · USD
ARCT SG&A Expenses
Latest reported$44.22Mperiod ending
Latest reported$44.22Mperiod ending
ARCT TTM SG&A Expenses ($3.22M → $44.22M)
TTM SG&A Expenses
High-resolution chart · PNG
ARCT sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 44,221,000 | |
| 43,570,000 | |
| 46,078,000 | |
| 44,431,000 | |
| 47,309,000 | |
| 49,287,000 | |
| 52,823,000 | |
| 52,950,000 | |
| 53,051,000 | |
| 53,960,000 | |
| 52,871,000 | |
| 52,224,000 | |
| 51,335,000 | |
| 49,103,000 | |
| 46,071,000 | |
| 46,917,000 | |
| 45,289,000 | |
| 44,338,000 | |
| 43,351,000 | |
| 41,579,000 | |
| 36,291,000 | |
| 30,669,000 | |
| 25,117,000 | |
| 18,374,000 | |
| 16,683,000 | |
| 15,719,000 | |
| 15,062,000 | |
| 14,312,000 | |
| 14,241,000 | |
| 19,018,000 | |
| 20,582,000 | |
| 19,796,000 | |
| 17,632,000 | |
| 11,490,000 | |
| 7,572,000 | |
| 6,203,000 | |
| 5,768,000 | |
| 5,079,000 | |
| 5,357,000 | |
| 5,396,000 | |
| 5,361,000 | |
| 5,161,000 | |
| 4,992,000 | |
| 5,103,000 | |
| 5,193,000 | |
| 5,339,000 | |
| 5,839,000 | |
| 5,443,000 | |
| 5,246,000 | |
| 4,773,000 | |
| 3,223,000 | |
| 2,365,000 | |
| 1,441,000 | |
| 764,000 |